Kentaro Hayashida
AsiaIntervention 2018;4:14-15, DOI: 10.4244/AIJV4I1A4
Transcatheter aortic valve implantation (TAVI) has become a wellestablished treatment for patients with high and intermediate surgical risk symptomatic severe aortic stenosis (AS). With the widening of the indications for TAVI, the incidence of bicuspid valve in the TAVI cohort is now increasing. Sometimes we encounter difficulty in crossing a bicuspid aortic valve, due to its anomalous anatomy, severe calcification, and enlarged ascending aorta. It is important to have a bail-out solution for cases where there is difficulty in crossing a native aortic valve in order to accomplish transfemoral TAVI successfully.
To download, please click below.